This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignee: Nanopharmaceuticals LLC. Active years: 2019-2022.
Company Filing History:
Years Active: 2019-2022
Title: The Innovative Contributions of Mehdi Rajabi
Introduction
Mehdi Rajabi is a prominent inventor based in Albany, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neuroendocrine tumors. With a total of 5 patents to his name, Rajabi's work is characterized by innovative approaches to medical treatment.
Latest Patents
One of Mehdi Rajabi's latest patents is titled "Composition and method for dual targeting in treatment of neuroendocrine tumors - Chemical compositions and methods of synthesis thereof." This patent focuses on the development of thyroid hormone αvβ3 integrin receptor antagonists that are conjugated to targets of the norepinephrine transporter (NET) or the catecholamine transporter. The compositions described in this patent exhibit a dual targeting effect, which enhances targeting efficiency in both the treatment and diagnostic imaging of neuroendocrine tumors.
Career Highlights
Rajabi is currently associated with Nanopharmaceuticals LLC, where he continues to advance his research and development efforts. His work is pivotal in creating effective therapeutic solutions for complex medical conditions.
Collaborations
Some of his notable coworkers include Shaker Ahmed Mousa and Ozlem O Karakus. Their collaborative efforts contribute to the innovative environment at Nanopharmaceuticals LLC.
Conclusion
Mehdi Rajabi's contributions to the field of pharmaceuticals, particularly in the treatment of neuroendocrine tumors, highlight his role as a leading inventor. His innovative patents and collaborative work continue to pave the way for advancements in medical science.